Clinical Trials

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03705806 2026-03-04

Palliative Thoracic ImmunoRT

Active not recruiting

12 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06719700 2026-03-03

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

47 enrolled

Small Cell Lung Carcinoma

NCT06943235 2026-02-11

Study of Probiotics Combined With Concurrent Hyperfractionated ChemoRadiotherapy and Adebrelimab Immunomaintenance in the Treatment of Limited-stage Small Cell Lung Cancer (LS-SCLC)

60 enrolled

DermatologicGastrointestinalGenitourinaryThoracic

Limited Stage Small Cell Lung Cancer

NCT05863052 2026-02-10

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

Active not recruiting

72 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasm Metastasis

NCT06610734 2026-02-09

SKY

202 enrolled

Small Cell Lung Cancer Extensive Stage

NCT05488626 2026-02-05

ARTIA-Lung

Phase NA Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT06810609 2026-01-27

InDuRanS

176 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04151940 2026-01-14

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

Phase NA Recruiting

80 enrolled

Phase NA Not yet recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07337096 2026-01-13

Electro-Acupuncture in Lung cancER : EALER Study

424 enrolled

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07293247 2025-12-22

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

164 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06102057 2025-12-17

PACCELIO

110 enrolled

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07258147 2025-12-02

Safety and Efficacy of Radiotherapy Combined With Immunochemotherapy in Pre-treated SCLC Patients With Liver Metastases

30 enrolled

Phase NA Active not recruiting

Lung Neoplasms

NCT06146920 2025-11-18

Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation

39 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT07231575 2025-11-18

Neoadjuvant SBRT and Tislelizumab (Immunotherapy) Plus Anlotinib for Resectable EGFR Wild-type NSCLC

Phase 2 Not yet recruiting

39 enrolled

Neoadjuvant Immunotherapy

NCT03176173 2025-11-05

Radical RADiotherapy and Immunotherapy for Metastatic CAncer of the Lung (RRADICAL)

Phase NA Completed

45 enrolled 13 charts

Phase 1 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT04926948 2025-10-22

Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma

20 enrolled

Pleural Mesothelial Neoplasm

NCT06127303 2025-09-05

Toripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLC

54 enrolled

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT07135882 2025-08-22

PRIME-Lung

420 enrolled

Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07111104 2025-08-08

ARIS

Completed

350 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT07014202 2025-07-30

Consolidation Radiotherapy vs. Observation in Oligoresidual Advanced Non-Small Cell Lung Cancer After Chemo-Immunotherapy

224 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07035860 2025-06-25

Efficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer

Not yet recruiting

34 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07034326 2025-06-24

Electroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer

Phase 2/3 Recruiting

405 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05667948 2025-05-22

Molecular Analysis and Treatment Options of Thymic Malignancies

Thymic epithelial tumor, Thymoma, Thymus Neoplasms

NCT06218901 2025-05-22

Life-Score

Phase 1 Not yet recruiting

Lung Neoplasms

NCT06966583 2025-05-12

NMN

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03035890 2025-04-01

Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer

Phase NA Completed

35 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06849167 2025-02-27

Immunotherapy Combined with Hypofractionated Concurrent Chemoradiotherapy Followed by Immunotherapy in LA-NSCLC

63 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06718309 2024-12-05

Chemotherapy Plus Immunotherapy Combined With SBRT as Neoadjuvant Therapy for Patients With Resectable NSCLC

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05945745 2024-11-29

Molecular Analysis and Treatment Options of SCLC

Small Cell Lung Carcinoma

NCT05902260 2024-09-19

NutriCim

Phase NA Completed

51 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06527898 2024-09-19

Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell Lung Cancer

Phase 1/2 Recruiting

45 enrolled

Small Cell Lung Carcinoma

NCT06518018 2024-07-24

HIBIC-NSCLC

Active not recruiting

80 enrolled

Barakat syndrome, Carcinoma, Non-Small-Cell Lung

NCT06503042 2024-07-16

A Study to Prospectively Validate Blood Markers Associated With Differences in Efficacy of Neoadjuvant Therapy for NSCLC

Not yet recruiting

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02949843 2024-06-28

Targeted Therapy in Treating Patients With Incurable Non-Small Cell Lung Cancer With Genetic Mutations

Phase 2 Terminated

19 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT05584267 2024-05-30

Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy

140 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06292052 2024-05-14

Relation Between Tumor-draining Lymph Nodes Metastasis Pattern and Non-small Cell Lung Cancer Neoadjuvant Immunotherapy Effectiveness

Completed

209 enrolled

Lung Neoplasms

NCT04638751 2024-04-05

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

BreastGastrointestinalThoracic

5,000 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT06341530 2024-04-02

Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer

33 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06326086 2024-03-22

Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.

240 enrolled

Carcinoma, Non-Small-Cell Lung, Sarcopenia

NCT06032052 2024-03-15

Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients

49 enrolled

Lung Neoplasms

NCT06287320 2024-03-01

The Predictive Biomarkers in Patients With Locally Advanced Non-small Cell Lung Cancer

Unknown

200 enrolled

Locally Advanced Non-small Cell Lung Cancer

NCT06207292 2024-01-16

STARTNEWERA-OM

Phase NA Unknown

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05418660 2023-09-18

I-STOP

Unknown

300 enrolled

BreastDermatologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung

NCT04435964 2023-03-24

G-DEFINER

Completed

247 enrolled

Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Urogenital Neoplasms

NCT04650490 2023-03-02

STICk-IM-NSCLC

Phase 2 Withdrawn

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT05111197 2023-02-21

TRAILOCLORI01

Phase 3 Unknown

112 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT05481775 2022-11-21

Evaluating Efficacy and Safety of Anlotinib Combined With Concurrent Chemoradiotherapy Followed by Consolidation Immunotherapy for Locally Advanced Non-small Cell Lung Cancer

Phase 2 Withdrawn

Locally Advanced Non-small Cell Lung Cancer

NCT05486988 2022-08-04

ctDNA as a Biomarker for Treatment in Advanced NSCLC

Unknown